-
-
-
-
-
-
-
Ortelius delivers criticism of Surgery Partners' performance
-
-
-
-
-
-
-
Surgery Partners (SGRY) PT Lowered at RBC Capital as 2026 Guide Prompts Selloff
-
-
-
-
-
-
-
Surgery Partners (SGRY) PT Lowered to $30 at Benchmark
-
-
-
-
-
-
-
JPMorgan Assumes Surgery Partners (SGRY) at Neutral
-
-
-
-
-
-
-
UBS Reiterates Buy Rating on Surgery Partners (SGRY)
-
-
-
-
-
-
-
KeyBanc Reiterates Sector Weight Rating on Surgery Partners (SGRY)
-
-
-
-
-
-
-
Surgery Partners (SGRY) PT Lowered to $35 at Benchmark
-
416,806 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

